Is interleukin-17 implicated in early knee osteoarthritis pathogenesis as in rheumatoid arthritis?

[21] Jeanneau K(1995)Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 44-174

[22] Rutkowska A(2000)A reappraisal of HAQ disability in rheumatoid arthritis Arthritis Rheum 43 2751-25

[23] Kallaur AP(2012)Early diagnosis to enable early treatment of pre-osteoarthritis Arthritis Res Ther 14 212-7

[24] Oliveira SR(2009)Risk factors for the development of rheumatoid arthritis Scand J Rheumatol 35 169-90

[25] Colado Simão AN(2017)Circulating concentrations of interleukin (IL)-17 in patients with multiple sclerosis: evaluation of the effects of gender, treatment, disease pattern and IL-23 receptor gene polymorphism Iran J Neurol 16 15-1557

[26] Onishi RM(2016)Th-17 cells and serum IL-17 in rheumatoid arthritis patients: Correlation with disease activity and severity Egypt Rheumatol 38 1-365

[27] Gaffen SL(2016)Relation between serum IL-17 level and risk of osteoporotic fracture in premenopausal rheumatoid arthritis patients: Clinical, radiological and laboratory studies Egypt Rheumat 38 85-56

[28] Reinert-Hartwall L(2014)Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year Arthritis Res Ther 16 R40-18

[29] Honkanen J(2010)The effects of adalimumab and methotrexate treatment on peripheral Th17 cells and IL-17/IL-6 secretion in rheumatoid arthritis patients Rheumatol Int 30 1553-144

[30] Salo HM(2005)The patient's perspective and rheumatoid arthritis disease activity indexes Rheumatology 44 360-1736

[21] Jeanneau K(1995)Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 44-174

[22] Rutkowska A(2000)A reappraisal of HAQ disability in rheumatoid arthritis Arthritis Rheum 43 2751-25

[23] Kallaur AP(2012)Early diagnosis to enable early treatment of pre-osteoarthritis Arthritis Res Ther 14 212-7

[24] Oliveira SR(2009)Risk factors for the development of rheumatoid arthritis Scand J Rheumatol 35 169-90

[25] Colado Simão AN(2017)Circulating concentrations of interleukin (IL)-17 in patients with multiple sclerosis: evaluation of the effects of gender, treatment, disease pattern and IL-23 receptor gene polymorphism Iran J Neurol 16 15-1557

[26] Onishi RM(2016)Th-17 cells and serum IL-17 in rheumatoid arthritis patients: Correlation with disease activity and severity Egypt Rheumatol 38 1-365

[27] Gaffen SL(2016)Relation between serum IL-17 level and risk of osteoporotic fracture in premenopausal rheumatoid arthritis patients: Clinical, radiological and laboratory studies Egypt Rheumat 38 85-56

[28] Reinert-Hartwall L(2014)Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year Arthritis Res Ther 16 R40-18

[29] Honkanen J(2010)The effects of adalimumab and methotrexate treatment on peripheral Th17 cells and IL-17/IL-6 secretion in rheumatoid arthritis patients Rheumatol Int 30 1553-144

[30] Salo HM(2005)The patient's perspective and rheumatoid arthritis disease activity indexes Rheumatology 44 360-1736